Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation

Oncogene

Volumn 25, Issue 40, 2006, Pages 5495-5506

  Jiang, L Q ^a,b   Feng, X ^a,b   Zhou, W ^a,b   Knyazev, P G ^c   Ullrich, A ^c   Chen, Z ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Cbp; Cell transformation; Csk; EGFR; Src

Indexed keywords

CSK BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN; PROTEIN AKT 1; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; TUMOR GROWTH;

ANIMALS; CARRIER PROTEINS; CAVEOLIN 1; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; HUMANS; MICE; NIH 3T3 CELLS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RNA INTERFERENCE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFECTION;

EID: 33748423528     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209554     Document Type: Article

References (49)

1. Baumeister U, Funke R, Ebnet K, Vorschmitt H, Koch S, Vestweber D. (2005). EMBO J 24: 1686-1695.
2. Baumgartner M, Angelisova P, Setterblad N, Mooney N, Werling D, Horejsi V et al. (2003). Blood 101: 1874-1881.
3. Biscardi JS, Belsches AP, Parsons SJ. (1998). Mol Carcinog 21: 261-272.
4. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ. (1999). J Biol Chem 274: 8335-8343.
5. Bivona TG, Perez De Castro I, Ahearn IM, Grana TM, Chiu VK, Lockyer PJ et al. (2003). Nature 424: 694-698.
6. Brdicka T, Pavlistova D, Leo A, Bruyns E, Korinek V, Angelisova P et al. (2000). J Exp Med 191: 1591-1604.
7. Cance WG, Liu ET. (1995). Breast Cancer Res Treat 35: 105-114.
8. Cao H, Sanguinetti AR, Mastick CC. (2004). Exp Cell Res 294: 159-171.
9. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. (1997). J Biol Chem 272: 6525-6533.
10. Davidson D, Bakinowski M, Thomas ML, Horejsi V, Veillette A. (2003). Mol Cell Biol 23: 2017-2028.
11. DeMali KA, Godwin SL, Soltoff SP, Kazlauskas A. (1999). Exp Cell Res 253: 271-279.
12. Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR et al. (1987). Cell 51: 1063-1070.
13. Dobenecker MW, Schmedt C, Okada M, Tarakhovsky A. (2005). Mol Cell Biol 25: 10533-10542.
14. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. (2003). Oncogene 22: 8983-8998.
15. Ishizawar R, Parsons SJ. (2004). Cancer Cell 6: 209-214.
16. Ishizawar RC, Tice DA, Karaoli T, Parsons SJ. (2004). J Biol Chem 279: 23773-23781.
17. Jiang T, Qiu Y. (2003). J Biol Chem 278: 15789-15793.
18. Karni R, Jove R, Levitzki A. (1999). Oncogene 18: 4654-4662.
19. Kassenbrock CK, Hunter S, Garl P, Johnson GL, Anderson SM. (2002). J Biol Chem 277: 24967-24975.
20. Kawabuchi M, Satomi Y, Takao T, Shimonishi Y, Nada S, Nagai K et al. (2000). Nature 404: 999-1003.
21. Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A. (1997). Nature 386: 181-186.
22. Kim YN, Dam P, Bertics PJ. (2002). Exp Cell Res 280: 134-147.
23. Kong M, Mounier C, Dumas V, Posner BI. (2003). J Biol Chem 278: 5837-5844.
24. Lev DC, Kim LS, Melnikova V, Ruiz M, Ananthaswamy HN, Price JE. (2004). Br J Cancer 91: 795-802.
25. Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH et al. (1994). J Cell Biol 126: 111-126.
26. Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D et al. (2003). J Biol Chem 278: 40057-40066.
27. Maa MC, Leu TH, McCarley DJ, Schatzman RC, Parsons SJ. (1995). Proc Natl Acad Sci USA 92: 6981-6985.
28. Mason CS, Springer CJ, Cooper RG, Superti-Furga G, Marshall CJ, Marais R. (1999). EMBO J 18: 2137-2148.
29. Matsuoka H, Nada S, Okada M. (2004). J Biol Chem 279: 5975-5983.
30. Nguyen DM, Schrump DS. (2004). Semin Thorac Cardiovasc Surg 16: 3-12.
31. Ohtake H, Ichikawa N, Okada M, Yamashita T. (2002). J Immunol 168: 2087-2090.
32. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. (1998). J Biol Chem 273: 5419-5422.
33. Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE. (1999). J Biol Chem 274: 17209-17218.
34. Rae JM, Lippman ME. (2004). Breast Cancer Res Treat 83: 99-107.
35. Roche S, Koegl M, Barone MV, Roussel MF, Courtneidge SA. (1995). Mol Cell Biol 15: 1102-1109.
36. Shien T, Doihara H, Hara H, Takahashi H, Yoshitomi S, Taira N et al. (2004). Breast Cancer 11: 367-373.
37. Shima T, Nada S, Okada M. (2003). Proc Natl Acad Sci USA 100: 14897-14902.
38. Simons K, Ikonen E. (1997). Nature 387: 569-572.
39. Smart EJ, Ying YS, Mineo C, Anderson RG. (1995). Proc Natl Acad Sci USA 92: 10104-10108.
40. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. (1996). J Biol Chem 271: 9690-9697.
41. Tremblay L, Hauck W, Aprikian AG, Begin LR, Chapdelaine A, Chevalier S. (1996). Int J Cancer 68: 164-171.
42. Tsuruda A, Suzuki S, Maekawa T, Oka S. (2004). FEBS Lett 560: 215-220.
43. Van Slyke P, Coll ML, Master Z, Kim H, Filmus J, Dumont DJ. (2005). Mol Cell Biol 25: 3831-3841.
44. Wang B, Lemay S, Tsai S, Veillette A. (2001). Mol Cell Biol 21: 1077-1088.
45. Wilson LK, Luttrell DK, Parsons JT, Parsons SJ. (1989). Mol Cell Biol 9: 1536-1544.
46. Xu S, Huo J, Tan JE, Lam KP. (2005). Mol Cell Biol 25: 8486-8495.
47. Yarden Y, Sliwkowski MX. (2001). Nat Rev Mol Cell Biol 2: 127-137.
48. Yayon A, Ma YS, Safran M, Klagsbrun M, Halaban R. (1997). Oncogene 14: 2999-3009.
49. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T et al. (2004). Mol Cell 13: 341-355.